March 11 (Reuters) - The Indian government has lowered the
price at which it buys AstraZeneca's COVID-19 vaccine
doses being produced by the Serum Institute of India (SII), the
federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200
rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a
news conference.
The SII, the world's biggest vaccine maker, has licensed the
vaccine from AstraZeneca and Oxford University and markets it as
COVISHIELD.
($1 = 72.6360 Indian rupees)
(Reporting by Neha Arora in New Delhi and Sachin Ravikumar in
Bengaluru; editing by Jason Neely)